|
Lung Cancer Clinical Trials
2,806 recruiting studies across 28 states and 50 cities.
Find Trials by State
California
908 trials · 7 cities
Texas
823 trials · 7 cities
Florida
407 trials · 4 cities
New York
315 trials · 1 city
Maryland
282 trials · 1 city
District of Columbia
281 trials · 1 city
Arizona
214 trials · 3 cities
Massachusetts
202 trials · 1 city
Tennessee
198 trials · 2 cities
Ohio
184 trials · 2 cities
Illinois
164 trials · 1 city
Colorado
152 trials · 2 cities
North Carolina
140 trials · 2 cities
Pennsylvania
132 trials · 1 city
Washington
123 trials · 1 city
Georgia
105 trials · 1 city
Oregon
86 trials · 1 city
Missouri
67 trials · 1 city
Nebraska
67 trials · 1 city
Kentucky
61 trials · 1 city
Minnesota
61 trials · 1 city
Wisconsin
58 trials · 1 city
Indiana
53 trials · 1 city
Oklahoma
47 trials · 2 cities
Louisiana
30 trials · 1 city
New Mexico
26 trials · 1 city
Nevada
22 trials · 1 city
Virginia
20 trials · 1 city
Find Trials by City
New York, NY
315 trials
Baltimore, MD
282 trials
Washington, DC
281 trials
Houston, TX
268 trials
Long Beach, CA
264 trials
Los Angeles, CA
264 trials
Boston, MA
202 trials
Chicago, IL
164 trials
Nashville, TN
151 trials
Philadelphia, PA
132 trials
Arlington, TX
129 trials
Dallas, TX
129 trials
Fort Worth, TX
129 trials
Miami, FL
125 trials
San Francisco, CA
123 trials
Seattle, WA
123 trials
Tampa, FL
123 trials
Denver, CO
115 trials
San Jose, CA
109 trials
Atlanta, GA
105 trials
Orlando, FL
98 trials
Raleigh, NC
97 trials
Cleveland, OH
94 trials
San Antonio, TX
93 trials
Mesa, AZ
91 trials
Phoenix, AZ
91 trials
Columbus, OH
90 trials
Portland, OR
86 trials
San Diego, CA
74 trials
Kansas City, MO
67 trials
Omaha, NE
67 trials
Jacksonville, FL
61 trials
Louisville, KY
61 trials
Minneapolis, MN
61 trials
Sacramento, CA
59 trials
Milwaukee, WI
58 trials
Austin, TX
56 trials
Indianapolis, IN
53 trials
Memphis, TN
47 trials
Charlotte, NC
43 trials
Oklahoma City, OK
42 trials
Colorado Springs, CO
37 trials
Tucson, AZ
32 trials
New Orleans, LA
30 trials
Albuquerque, NM
26 trials
Las Vegas, NV
22 trials
Virginia Beach, VA
20 trials
El Paso, TX
19 trials
Fresno, CA
15 trials
Tulsa, OK
5 trials
Drugs Being Studied for Lung Cancer
carboplatin127Pembrolizumab110Pemetrexed88Cisplatin59Paclitaxel50Atezolizumab43Osimertinib42Docetaxel39Durvalumab33Nivolumab33Etoposide29Tislelizumab24Nab paclitaxel24Bevacizumab24Cemiplimab21Gemcitabine20Cetuximab17Ivonescimab14Lurbinectedin13Cyclophosphamide13Tarlatamab12BL-B01D112Topotecan12Sintilimab12
Recently Updated Trials
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsPhase 2Daiichi Sankyo
- A Registry for People With Lung CancerMemorial Sloan Kettering Cancer Center
- RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II TrialPhase 2Masonic Cancer Center, University of Minnesota
- Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine TumorsPhase 2National Cancer Institute (NCI)
- Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialPhase 3National Cancer Institute (NCI)
- A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsPhase 1/Phase 2Terremoto Biosciences Inc.
- Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)Phase 3Merck Sharp & Dohme LLC
- Metabolic Biomarkers Predicting Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerPhase 2Hospital das Clínicas de Ribeirão Preto
- A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid TumorsPhase 1/Phase 2GI Innovation, Inc.
- Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 ChangePhase 2National Cancer Institute (NCI)
Frequently Asked Questions
How many Lung Cancer clinical trials are currently recruiting?
There are 2,806 Lung Cancer clinical trials currently recruiting participants across the United States.
Which states have the most Lung Cancer trials?
The states with the most Lung Cancer clinical trials are California, Texas, Florida.
What phases are Lung Cancer trials in?
Lung Cancer trials span multiple phases: Not specified (666), Phase 2 (627), NA (523).
Can healthy volunteers join Lung Cancer trials?
Most Lung Cancer trials require participants to have the condition. None of the currently recruiting trials explicitly accept healthy volunteers.
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.